Paliperidone Eg 100 Mg

Paliperidone, the active ingredient in Paliperidone Eg 100 Mg, is an atypical antipsychotic presented as a 100 mg formulation for intravenous use. It is indicated for the treatment of schizophrenia and related psychotic disorders in adults.

GNH USA supplies Paliperidone Eg 100 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone acts on dopamine and serotonin pathways to manage psychotic conditions. - Schizophrenia: alleviates hallucinations, delusions and thought disorder. - Schizoaffective disorder: reduces mood‑related psychotic symptoms. - Acute psychotic episodes: stabilises acute exacerbations in diagnosed patients.

Paliperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Headache - Drowsiness - Constipation - Dry mouth - Weight gain - Restlessness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Seizures - Orthostatic hypotension - Elevated prolactin levels - Severe allergic reactions

When prescribing Paliperidone, clinicians should consider several safety aspects. - Cardiovascular monitoring: assess baseline ECG and blood pressure. - Metabolic assessment: monitor weight, glucose and lipid levels regularly. - Movement disorders: watch for early signs of tardive dyskinesia. - Orthostatic hypotension: advise patients to rise slowly from sitting or lying positions. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Palionic (…)